-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Mubritinib is a drug that is used to treat various types of cancer, including acute myeloid leukemia, myelodysplastic syndromes, and relapsed or refractory B-cell lymphomas.
It is a synthetic agent that is derived from a natural product called swainsonine, which is found in several species of fungi.
The synthetic routes of mubritinib can be broadly classified into four categories: classical organic synthesis, combinatorial chemistry, medicinal chemistry, and total synthesis.
Classical Organic Synthesis:
Classical organic synthesis is the traditional method of synthesizing organic compounds.
It involves the step-by-step assembly of the molecule through the use of classical organic reagents, such as alkylating agents, halides, and bases.
This method requires a detailed understanding of the molecular structure of the compound and the use of protecting groups to protect the biologically active portions of the molecule during the synthesis.
Combinatorial Chemistry:
Combinatorial chemistry is a modern approach to drug discovery that involves the synthesis and screening of a large library of compounds.
The library is generated by combining various building blocks with different chemical and physical properties.
The compounds are then screened for their biological activity using high-throughput screening methods.
The advantage of this method is that it allows for the rapid identification of active compounds, and it can be used to identify lead compounds for further development.
Medicinal Chemistry:
Medicinal chemistry involves the synthesis and modification of a lead compound to optimize its biological activity and pharmacokinetics.
This involves the use of various medicinal chemistry techniques, such as the introduction of functional groups, the modification of the molecular scaffold, and the optimization of the pharmacokinetic properties.
The goal of medicinal chemistry is to develop a drug that has a high degree of selectivity and specificity for the target protein, as well as a favorable safety profile.
Total Synthesis:
Total synthesis refers to the complete synthesis of a natural product or a complex organic compound.
It involves the assembly of all the atoms in the molecule through the use of various synthetic methods, such as classical organic synthesis, combinatorial chemistry, and medicinal chemistry.
Total synthesis is a challenging task that requires a deep understanding of the molecular structure and the use of advanced synthetic methods.
In conclusion, the synthetic routes of mubritinib involve the use of various synthetic methods and techniques to generate the molecule.
These methods include classical organic synthesis, combinatorial chemistry, medicinal chemistry, and total synthesis.
The choice of synthetic method depends on the complexity of the molecule and the desired properties of the final product.
The development of new synthetic methods and the continued advancement of synthetic techniques will have a significant impact on the future of drug discovery and development.